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Hepatitis C virus (HCV) is resistant to the antiviral cytokine type I interferon, representing a major clinical
problem. Garaigorta and Chisari (2009) reveal that HCV uses the activation of the ds-RNA-dependent protein
kinase R, which phosphorylates and inhibits the translation initiation factor eIF-2a, to block translation of
interferon-stimulated genes.Hepatitis C virus (HCV) infection is a major
cause of chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. With
more than 170 million people chronically
infected by HCV worldwide, this disease
has emerged as a serious global health
problem (Alter and Seeff, 2000). There is
no vaccine available, and the only means
to control the disease is through antiviral
therapy, largely by the combination of
type I interferon (IFN) and ribavirin.
However, this antiviral therapy, though
effective, has limited success, and many
individuals become nonresponsive.
Monotherapy based on IFN alone is inef-
fective in the majority of HCV-infected
patients. Although multiple mechanisms
have been proposed for how HCV coun-
teracts the antiviral effects of IFN, the
basis of HCV’s resistance to IFN therapy
is not clear (Feld and Hoofnagle, 2005).
Several HCV proteins inhibit JAK-STAT
signaling, NS5A inhibits IL-8 induction,
and HCV core protein inhibits the induc-
tion of SOCS-3 and transcriptionally
suppresses interferon-stimulated genes
(ISGs). Also, NS5A, E2, and the presence
of an internal ribosome entry site (IRES) in
the HCV genome serve to overcome the
translation-inhibiting function of the eIF-
2a kinase, PKR (Wohnsland et al., 2007).The cell culture system for productive
HCV infection (Zhong et al., 2006) allows
more direct measurements of the effects
of IFN during the lifecycle of the virus.
Although IFN induces ISGs in the liver,
HCV infection still persists, and it was
previously suggested that HCV might
block the effector functions of ISGs in
the infected cells (Alter and Seeff, 2000).
In the current issue of Cell Host &
Microbe, Garaigorta and Chisari (2009)
have addressed the question of IFN-resis-
tant mechanisms of HCV using the cell
culture model based on the hepatic cell
line Huh-7 infected with HCV. A compar-
ison between the effects of IFN on full-
length replicon cells versus persistently
infected cells revealed a clear distinction,
with replicon cells being more sensitive to
IFN effects than the persistent infection,
as previously noted. However, in the
context of persistent infection and under
conditions in which IFN treatment had
little effect on intracellular HCV RNA or
proteins, virus-infected cells produced
many fewer ISGs (i.e., MxA and ISG15),
and this effect was posttranscriptional
because ISG mRNA levels were not
affected. Pulse-labeling experiments
showed that, whereas HCV infection had
little effect on global host cell proteinsynthesis, treatment with IFN inhibited
protein translation in a dose-dependent
manner. Because eIF-2a, a key transla-
tional regulator, is phosphorylated by the
ds-RNA-dependent kinase PKR, which
downregulates its activity (Garcı´a et al.,
2006), an examination of the kinetics of
virus infection revealed that HCV infection
is accompanied by phosphorylation of
PKR and of eIF-2a, although viral protein
accumulation is not altered. Other eIF-2a
kinases, namely PERK and GCN2, were
not involved, and the process was type I
IFN independent. Both PKR and eIF-2a
phosphorylation were more strongly
induced in IFN-treated HCV infected cells,
although the accumulation of HCV RNA
was not impaired. Further, HCV replica-
tion was also not affected in infected cells
expressing short hairpin RNA to block
PKR expression. However, upon PKR
depletion by siRNA, HCV infection
became more sensitive to the antiviral
effects of IFN. In these PKR-depleted
cells, ISG protein expression was re-
stored, correlating with an enhanced
reduction of HCV RNA indicating that
ISG proteins mediate the antiviral effects
of IFN. Overall, the work of Garaigorta
and Chisari suggests that HCV-induced
PKR phosphorylation is responsible forecember 17, 2009 ª2009 Elsevier Inc. 495
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Figure 1. PKR Activation and eIF-2a Phosphorylation Prevent Protein Synthesis of ISGs, but Not of HCV Proteins
Phosphorylation of PKR and eIF-2a is observed in human hepatoma cells expressing a replication-competent JFH-1 RNA, and HCV-IRES translation is known to
be relatively resistant to eIF-2a phosphorylation (Shimoike et al., 2009). The mechanism of resistance of HCV-IRES to eIF-2a phosphorylation is not known. Initi-
ation of HCV proteins is reported to be resistant to reduced ternary eIF-2 initiation complex formation (Robert et al., 2006), and the subgenomic mRNA of Sindbis
virus (a member of the alphavirus family) is translated efficiently in cells with eIF-2a completely phosphorylated due to a highly stable RNA hairpin loop located
downstream of the AUG initiation codon (Ventoso et al., 2006). Based on these previous observations, it is proposed that there are similar mechanisms of
HCV-IRES escape from PKR action. In the absence of eIF-2a availability, HCV-IRES might stall the ribosome on the correct site to initiate translation, thus
bypassing the requirement for a functional eIF-2. In the case of HCV, the existence of a 50 untranslated RNA and an IRES could act as a restriction site to escape
the need for eIF-2a phosphorylation. There are at least five conserved stem-loop structures of unknown function present within the first 500 nucleotides of the
core-protein coding sequence. Whether any of these structures contribute to the escape of HCV from eIF-2a phosphorylation remains to be established.
Undoubtedly, the mechanism of HCV mRNA escape from PKR phosphorylation deserves investigation to unravel the paradigm of PKR and HCV.
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Previewsthe reduced levels of ISG proteins in
infected cells and, in turn, for the resis-
tance of HCV to the antiviral effects of
IFN. The findings may have an important
impact on the study of HCV infection
and may provide a rationale for HCV’s
resistance to IFN treatment observed in
the clinic. Blocking PKR with selective
inhibitors in HCV patients receiving IFN
therapy may increase the protein levels
of ISGs, and these proteins, in turn, would
be expected to enhance the antiviral
effects of IFN.
How representative is the replicon
model versus the HCV infection model
used by Garaigorta and Chisari (2009)
for studying virus-host cell interactions?
Clearly, there are differences in IFN sensi-
tivity between the two models that need496 Cell Host & Microbe 6, December 17, 200to be clarified. In the virus-cell system
used by Garaigorta and Chisari (2009),
suppression of PKR expression enhances
the antiviral effect of IFN against HCV,
indicating that ISGs are responsible for
the control of HCV infection. The identifi-
cation of the ISGs responsible for the inhi-
bition of HCV will be required. This could
be addressed in the cell culture model
by knocking down selective ISGs and
determining the extent of virus replication.
It is likely that several ISGs will contribute
to the control of HCV infection and that
virus escape mutants will arise. The cell
culture model system would also be
useful to examine whether the com-
bination of IFN and ribavirin as used in
therapy can contribute to introduce higher
frequency of mutations that could push9 ª2009 Elsevier Inc.the virus toward the threshold of ‘‘error
catastrophe’’ and extinction (Feld and
Hoofnagle, 2005).
It is well documented that HCV uses
several strategies to escape the antiviral
action of IFN; among them, NS5A and
E2 function to antagonize the effects of
PKR (Gale and Foy, 2005). The con-
tribution of these two viral proteins when
PKR is phosphorylated in the current
JFH1 cell culture model merits inves-
tigation. Although this study shows a
clear role of PKR in HCV infection, it
does not explain how HCV escapes the
translational block induced by eIF-2a
phosphorylation. A scheme for how HCV
escapes PKR action according to Garai-
gorta and Chisari’s findings is shown in
Figure 1.
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Vaccinia virus uses A36 to recruit the actin polymerization effectors Nck andN-WASP to drive actin tail forma-
tion. Now, Dodding and Way identify functional orthologs of A36 in other vertebrate poxviruses that harbor
varying numbers of Nck-binding sites and can substitute for A36 despite no sequence homology.The host cell actin cytoskeleton is one of
the prime targets of pathogens during
initial contact, entry, or intra- and intercel-
lular dissemination. Vaccinia virus, a close
relative of the smallpox virus, was discov-
ered to induce the formation of actin
comet tails almost 15 years ago (Cudmore
et al., 1995) and has since developed into
a key model system to study signal trans-
duction pathways leading to actin cyto-
skeletal reorganization at the plasma
membrane. Vaccinia virus is a member
of the genus Orthopoxvirus, one out of
eight genera in the subfamily Chordopox-
virinae. The replication cycle of vaccinia
virus is quite complex, as it gives rise to
two variants of infectious progeny: the
intracellular mature virus (IMV), which
is only released upon cell lysis, and
the extracellular enveloped virus (EEV).
IMV wrapped by membrane cisternae
develops into intracellular enveloped virus
(IEV) and is transported on microtubules
to the cell periphery. Upon fusion withthe plasma membrane, the virus now
termed cell-associated extracellular virus
(CEV) induces the polymerization of actin
filaments into an actin tail, propelling the
virus away from the surface into neigh-
boring cells or until release as EEV (Rob-
erts and Smith, 2008). IEV delivery to the
cell periphery requires the microtubule
motor Kinesin-1, which binds the integral
viral membrane protein A36. Remarkably,
the same protein becomes localized
underneath the extracellular CEV, disso-
ciates from Kinesin-1, and upon tyrosine
phosphorylation by Src and Abl family
kinases, switches to signaling actin poly-
merization (Mu¨nter et al., 2006). Phos-
phorylation on two key residues in A36,
Y112 and Y132, creates binding sites for
the Src homology 2 (SH2)—domains of
Nck and Grb2 adaptor proteins, respec-
tively, which physically link to the actin-
binding proteins WIP and N-WASP (Fig-
ure 1). N-WASP activates the nucleation
of actin filaments through interactionwith actin and Arp2/3 complex, a seven-
subunit complex driving dynamic actin
assembly during migration, adhesion, or
vesicle trafficking (Goley and Welch,
2006). Both Nck and N-WASP are essen-
tial for vaccinia actin tail formation, and
although Grb2 is less important, it stabi-
lizes the complex beneath the virus
(Snapper et al., 2001; Weisswange et al.,
2009).
The described signaling pathway is so
far thought to be conserved within the
genus Orthopoxvirus. However, actin tails
were recently also observed in two other
members of the poxvirus family: Yaba-
like disease virus (YLDV) and myxoma
(Duteyrat et al., 2006; Law et al., 2004),
although the underlying mechanism re-
mained unknown due to the absence of
an obvious A36 ortholog in these viruses.
In this issue of Cell Host & Microbe, Dod-
ding and Way have solved this puzzle by
identifying the gene encoding the func-
tional homolog in YLDV, 126R (Doddingecember 17, 2009 ª2009 Elsevier Inc. 497
